about
Systematic versus opportunistic risk assessment for the primary prevention of cardiovascular diseasep75(NTR)-dependent activation of NF-κB regulates microRNA-503 transcription and pericyte-endothelial crosstalk in diabetes after limb ischaemiaHuman Pericardial Fluid Contains Exosomes Enriched with Cardiovascular-Expressed MicroRNAs and Promotes Therapeutic Angiogenesis.Copper Transport Protein Antioxidant-1 Promotes Inflammatory Neovascularization via Chaperone and Transcription Factor Function.Coronary Artery-Bypass-Graft Surgery Increases the Plasma Concentration of Exosomes Carrying a Cargo of Cardiac MicroRNAs: An Example of Exosome Trafficking Out of the Human Heart with Potential for Cardiac Biomarker Discovery.MicroRNA-15a and microRNA-16 impair human circulating proangiogenic cell functions and are increased in the proangiogenic cells and serum of patients with critical limb ischemia.The role of cell salvage autotransfusion in abdominal aortic aneurysm surgery.Role of microRNAs in diabetes and its cardiovascular complications.The reporting quality of systematic reviews and meta-analyses in vascular surgery needs improvement: a systematic review.Endovascular aneurysm repair in nonagenarians: a systematic review.Do surgery journals insist on reporting by CONSORT and PRISMA? A follow-up survey of 'instructions to authors'.Does alphabetisation ensure randomisation of single best answer questions?Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation.A survey of instructions to authors in surgical journals on reporting by CONSORT and PRISMA.Corrigendum: Canagliflozin, dapagliflozin and empagliflozin monotherapy for treating type 2 diabetes: systematic review and economic evaluation.Gestational diabetes mellitus impairs fetal endothelial cell functions through a mechanism involving microRNA-101 and histone methyltransferase enhancer of zester homolog-2.Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis.miR-15a/-16 Inhibit Angiogenesis by Targeting the Tie2 Coding Sequence: Therapeutic Potential of a miR-15a/16 Decoy System in Limb Ischemia.Comparing the Attitudes and Knowledge Toward Incident Reporting in Junior Physicians and Nurses in a District General HospitalDiabetes, microRNAs and exosomes: Les liaisons dangereusesOutbreak of Clostridium perfringens food poisoning linked to leeks in cheese sauce: an unusual sourcePotential excess spend in primary care due to NHS drug tariff variability in vitamin D preparationsKnowledge about E-Cigarettes and Tobacco Harm Reduction among Public Health Residents in Europe
P50
Q24186332-B95E7AB4-BC52-4731-94A2-5B1EEF848BDDQ28117855-62877C0E-89FC-4C76-BF93-676CB0F2774DQ29871466-C2C6D8D6-011E-4A0F-B2E7-29B83897099FQ30666915-1E28908E-5FD1-4783-95D3-E384A005B510Q36003227-593C9F38-4BC0-4016-9D54-4FE335D6C5F2Q36739746-BDF93A96-92F0-4DDC-90B0-97BF0F9310EDQ37894961-6CC296EC-05C8-4733-BA2F-61A63670205BQ37953896-4C476ED5-E3BF-4942-A331-552666B787C0Q38275408-D141F29A-72FE-47C9-BA07-6B288386F0C9Q38275645-9D01EE73-9E0C-434C-A03B-2610774C51F2Q38356874-32C72B0E-7178-4091-9106-3E9D681364FFQ43508515-86BEC2AD-AFA1-4EF2-B5EE-AAA9ADD82218Q45930171-92DD693E-9BF0-40C1-8BF6-B1AD39F0D84AQ46070720-E694CB52-71B4-4C79-B6CD-B0E6BC52EE5CQ52808478-FDE00750-0046-4A89-8EC5-D27E3A6BC1D5Q54176556-2FD28254-B523-404F-8429-9019A594E689Q54982565-8A86E8CA-8F8B-49E4-A478-810F4FEB55B7Q64997497-2BE8DEFC-F43D-4487-AB4A-0CE7B93725ECQ87474934-031C1BB6-1B18-4313-8B26-154E7188E93DQ87977834-3348A44C-5CF2-4F1E-8FA5-B469F86378F2Q89897983-00C4C724-7FDF-4D6D-8DA5-661176794350Q90672113-1E0F9E6B-CE60-4859-8FE2-5C13BD835780Q92854224-5E753AE7-3C2A-4BBD-ADE7-86B2FD08F232
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Saran Shantikumar
@ast
Saran Shantikumar
@en
Saran Shantikumar
@es
Saran Shantikumar
@nl
Saran Shantikumar
@sl
type
label
Saran Shantikumar
@ast
Saran Shantikumar
@en
Saran Shantikumar
@es
Saran Shantikumar
@nl
Saran Shantikumar
@sl
prefLabel
Saran Shantikumar
@ast
Saran Shantikumar
@en
Saran Shantikumar
@es
Saran Shantikumar
@nl
Saran Shantikumar
@sl
P106
P1153
26325884100
P31
P496
0000-0002-8565-5385